Globally, dengue (DENV) fever has appeared as the most widespread vector-borne disease,
affecting more than 100 million individuals annually. No approved anti-DENV therapy or …

Background Due to dengue virus disease, half of the world population is at severe health
risk. Viral encoded NS2B-NS3 protease complex causes cleavage in the nonstructural …

Dengue fever has been a global health concern. Mitigation is a challenging problem due to
non-availability of workable treatments. The most difficult objective is to design a perfect anti …

Dengue, a mosquito-borne disease, has appeared as a major infectious disease globally.
The virus requires its proteins to replicate and reproduce in the host cell. The NS3 protease …

Abstract The NS2B-NS3 protease is essential for the replication process of Dengue Virus,
which make it an attractive target for anti-virus drugs. Since a considerable number of NS2B …

Medicinal plants have been used from the beginning of human civilization against various
health complications. Dengue virus (DENV) has emerged as one of the most widespread …

Approximately 3.9 billion individuals are vulnerable to dengue infection, a prevalent cause
of tropical diseases worldwide. Currently, no drugs are available for preventing or treating …

Dengue Virus (DENV) is a serious threat to human life worldwide and is one of the most
dangerous vector-borne diseases, causing thousands of deaths annually. We constructed a …

Dengue fever has been a global health concern affecting 3 billion individuals worldwide and
50-100 million fresh infections per year, which is an acute viral infection caused by four …

The spread of the Dengue virus over the world, as well as multiple outbreaks of different
serotypes, has resulted in a large number of deaths and a medical emergency, as no viable …